Scutellarin resensitizes oxaliplatin-resistant colorectal cancer cells to oxaliplatin treatment through inhibition of PKM2

Although oxaliplatin is an effective chemotherapeutic drug commonly used for colorectal cancer (CRC) treatment, drug resistance usually occurs during the long-term use of it. It is urgent to create strategies to reduce the resistance of CRC cells to oxaliplatin. Oxaliplatin-resistant CRC cells (OR-S...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Ther Oncolytics
Autors principals: Sun, Wei, Ge, Yang, Cui, Junpeng, Yu, Yifan, Liu, Baolin
Format: Artigo
Idioma:Inglês
Publicat: American Society of Gene & Cell Therapy 2021
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8065260/
https://ncbi.nlm.nih.gov/pubmed/33981825
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2021.03.010
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars